Bronchiectasis Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

List of Tables

REPORT HIGHLIGHT

Bronchiectasis Drugs Market size was valued at USD 481.71 Million in 2022, expanding at a CAGR of 5.1 % from 2023 to 2030.

Pharmaceutical solutions designed for bronchiectasis address the challenges associated with this persistent lung condition, characterized by the inflammation and enlargement of the bronchial tubes. These medications are tailored to alleviate symptoms such as persistent coughing, excessive mucus production, and the susceptibility to recurring lung infections. Treatment typically includes the administration of antibiotics to combat or prevent infections, bronchodilators to expand air passages, and mucolytics to facilitate mucus clearance. The treatment approach is individualized to cater to the specific needs of each patient, with a primary focus on symptom management, infection prevention, and the enhancement of overall lung function, ultimately aiming to enhance the quality of life for those living with bronchiectasis.

Bronchiectasis Drugs Market- Market Dynamics

Rising awareness of this often-underdiagnosed condition propel market demand

Advances in medical knowledge and diagnostic capabilities have led to an uptick in the identification of bronchiectasis cases. Additionally, the aging demographic and the surge in chronic respiratory ailments have heightened the demand for more effective treatment solutions. This increased awareness, along with a growing patient population, has prompted pharmaceutical companies and researchers to allocate resources towards the development of enhanced strategies for managing bronchiectasis. A driving force behind these endeavors is the commitment to improving the well-being of bronchiectasis patients while lessening the burden of recurrent infections and associated symptoms.

Bronchiectasis Drugs Market- Key Insights

In line with the insights provided by our research analyst, the global market for Bronchiectasis Medications is anticipated to experience an approximate annual growth rate of 5.1% throughout the forecast period from 2023 to 2030.

The Bronchiectasis Drugs sector is poised for substantial expansion, primarily driven by the increasing recognition of a medical condition that often goes undetected.

In terms of Drug Class categorization, Antibiotics were forecasted to dominate the market in the year 2022.

When considering the segmentation based on Route of Administration, Oral medications emerged as the leading category in 2022.

Geographically, North America took the lead in revenue generation in 2022.

Bronchiectasis Drugs Market- Segmentation Analysis:

The worldwide market for Bronchiectasis Medications is structured around key factors including Drug Class, Route of Administration, Distribution Channel, and Region.

When it comes to Drug Class categorization, this market is categorized into four distinct segments: Antibiotics, Mucolytics, Bronchodilators, and Anti-inflammatory agents. Notably, Antibiotics take the lead in this classification. Their significance in bronchiectasis therapy lies in their role in managing and preventing the reoccurrence of lung infections, a common complication associated with the condition. Antibiotics are instrumental in targeting and eradicating the microbes responsible for these infections, ultimately leading to improved patient symptoms, lung function, and overall quality of life.

Bronchiectasis Drugs Market- Geographical Insights

From a geographical perspective, this market spans across the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within these regions, individual countries play a pivotal role in driving business dynamics.

Several factors have converged to stimulate the heightened demand for bronchiectasis medications in North America. Firstly, the region's aging population is increasingly susceptible to chronic respiratory ailments, including bronchiectasis. Secondly, the advancement of diagnostic expertise and healthcare practitioners' knowledge has led to more precise and timely diagnoses, significantly contributing to the demand for these medications.

Bronchiectasis Drugs Market- Competitive Landscape:

The bronchiectasis pharmaceutical market is distinguished by a limited selection of specialized treatments approved for this condition. Leading pharmaceutical companies offer some of the primary treatment options. Nevertheless, the field is somewhat limited in terms of specialized medications, with therapy predominantly relying on repurposed antibiotics, bronchodilators, and mucolytics. This limitation has created a niche for the development of new drugs, as companies explore innovative therapeutics designed to address the root causes of bronchiectasis and enhance patient outcomes. This presents promising prospects for growth and advancement within the sector.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BRONCHIECTASIS DRUGS MARKET KEY PLAYERS

GlaxoSmithKline plc
Novartis AG
Pfizer Inc.
AstraZeneca plc
Boehringer Ingelheim International GmbH
Roche Holding AG
Teva Pharmaceutical Industries Ltd.
Bayer AG
Sanofi S.A.
Sunovion Pharmaceuticals Inc.
Mylan N.V.
Cipla Ltd.
Grifols S.A.
Insmed Incorporated
Arbor Pharmaceuticals LLC

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY DRUG CLASS

Antibiotics
Mucolytics
Bronchodilators
Anti-inflammatory agents

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY ROUTE OF ADMINISTRATION

Oral
Inhalation
Intravenous

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY DISTRIBUTION CHANNEL

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV1785

1. Bronchiectasis Drugs Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Bronchiectasis Drugs Market Snippet by Drug Class
- 2.1.2. Bronchiectasis Drugs Market Snippet by Route of Administration
- 2.1.3. Bronchiectasis Drugs Market Snippet by Distribution Channel
- 2.1.4. Bronchiectasis Drugs Market Snippet by Country
- 2.1.5. Bronchiectasis Drugs Market Snippet by Region
2.2. Competitive Insights

3. Bronchiectasis Drugs Key Market Trends

3.1. Bronchiectasis Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Bronchiectasis Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Bronchiectasis Drugs Market Opportunities
3.4. Bronchiectasis Drugs Market Future Trends

4. Bronchiectasis Drugs Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Bronchiectasis Drugs Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Bronchiectasis Drugs Market Landscape

6.1. Bronchiectasis Drugs Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Bronchiectasis Drugs Market - By Drug Class

7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
- 7.1.2. Antibiotics
- 7.1.3. Mucolytics
- 7.1.4. Bronchodilators
- 7.1.5. Anti-inflammatory agents

8. Bronchiectasis Drugs Market - By Route of Administration

8.1. Overview
- 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
- 8.1.2. Oral
- 8.1.3. Inhalation
- 8.1.4. Intravenous

9. Bronchiectasis Drugs Market - By Distribution Channel

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
- 9.1.2. Hospital Pharmacies
- 9.1.3. Retail Pharmacies
- 9.1.4. Online Pharmacies

10. Bronchiectasis Drugs Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Bronchiectasis Drugs Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Bronchiectasis Drugs Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Bronchiectasis Drugs Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Bronchiectasis Drugs Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Bronchiectasis Drugs Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bronchiectasis Drugs Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. GlaxoSmithKline plc
- 11.2.2. Novartis AG
- 11.2.3. Pfizer Inc.
- 11.2.4. AstraZeneca plc
- 11.2.5. Boehringer Ingelheim International GmbH
- 11.2.6. Roche Holding AG
- 11.2.7. Teva Pharmaceutical Industries Ltd.
- 11.2.8. Bayer AG
- 11.2.9. Sanofi S.A.
- 11.2.10. Sunovion Pharmaceuticals Inc.
- 11.2.11. Mylan N.V.
- 11.2.12. Cipla Ltd.
- 11.2.13. Grifols S.A.
- 11.2.14. Insmed Incorporated
- 11.2.15. Arbor Pharmaceuticals LLC

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

Product Code: ANV1785

List of Tables

TABLE List of data Route of Administrations
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Bronchiectasis Drugs Market: Drug Class Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Drug Class
TABLE Global Bronchiectasis Drugs Market, by Drug Class 2018-2030 (USD Million)
TABLE Bronchiectasis Drugs Market: Route of Administration Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Route of Administration
TABLE Global Bronchiectasis Drugs Market, by Route of Administration 2018-2030 (USD Million)
TABLE Bronchiectasis Drugs Market: Distribution Channel Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
TABLE Global Bronchiectasis Drugs Market, by Distribution Channel 2018-2030 (USD Million)
TABLE Bronchiectasis Drugs Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Bronchiectasis Drugs Market, by Region 2018-2030 (USD Million)
TABLE North America Bronchiectasis Drugs Market, by Country, 2018-2030 (USD Million)
TABLE North America Bronchiectasis Drugs Market, by Drug Class, 2018-2030 (USD Million)
TABLE North America Bronchiectasis Drugs Market, by Route of Administration, 2018-2030 (USD Million)
TABLE North America Bronchiectasis Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
TABLE Europe Bronchiectasis Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Europe Bronchiectasis Drugs Market, by Drug Class, 2018-2030 (USD Million)
TABLE Europe Bronchiectasis Drugs Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Europe Bronchiectasis Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
TABLE Asia Pacific Bronchiectasis Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Bronchiectasis Drugs Market, by Drug Class, 2018-2030 (USD Million)
TABLE Asia Pacific Bronchiectasis Drugs Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Asia Pacific Bronchiectasis Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
TABLE Latin America Bronchiectasis Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Bronchiectasis Drugs Market, by Drug Class, 2018-2030 (USD Million)
TABLE Latin America Bronchiectasis Drugs Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Latin America Bronchiectasis Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
TABLE Middle East and Africa Bronchiectasis Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Bronchiectasis Drugs Market, by Drug Class, 2018-2030 (USD Million)
TABLE Middle East and Africa Bronchiectasis Drugs Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Middle East and Africa Bronchiectasis Drugs Market, by Distribution Channel, 2018-2030 (USD Million)

Bronchiectasis Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

Description

Table of Contents

List of Tables

REPORT HIGHLIGHT

Bronchiectasis Drugs Market- Segmentation Analysis:

Bronchiectasis Drugs Market- Competitive Landscape:

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BRONCHIECTASIS DRUGS MARKET KEY PLAYERS

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY DRUG CLASS

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY ROUTE OF ADMINISTRATION

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY DISTRIBUTION CHANNEL

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY REGION

Table of Contents

1. Bronchiectasis Drugs Market Overview

2. Executive Summary

3. Bronchiectasis Drugs Key Market Trends

4. Bronchiectasis Drugs Industry Study

5. Bronchiectasis Drugs Market: COVID-19 Impact Analysis

6. Bronchiectasis Drugs Market Landscape

7. Bronchiectasis Drugs Market - By Drug Class

8. Bronchiectasis Drugs Market - By Route of Administration

9. Bronchiectasis Drugs Market - By Distribution Channel

10. Bronchiectasis Drugs Market- By Geography

11. Key Vendor Analysis- Bronchiectasis Drugs Industry

12. 360 Degree Analyst View

13. Appendix

List of Tables